TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
256,602
|
229,142
|
162,404 |
Financial expenses |
806
|
7
|
1 |
Earnings before taxes |
85,276
|
117,171
|
44,962 |
EBITDA |
82,302
|
115,852
|
45,665 |
Total assets |
187,334
|
169,194
|
143,669 |
Current assets |
177,040
|
161,682
|
135,895 |
Current liabilities |
82,328
|
50,779
|
21,019 |
Equity capital |
98,147
|
114,203
|
119,009 |
- share capital |
51
|
47
|
49 |
Employees (average) |
17
|
11
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.4%
|
67.5%
|
82.8% |
Turnover per employee |
15,094
|
20,831
|
27,067 |
Profit as a percentage of turnover |
33.2%
|
51.1%
|
27.7% |
Return on assets (ROA) |
46.0%
|
69.3%
|
31.3% |
Current ratio |
215.0%
|
318.4%
|
646.5% |
Return on equity (ROE) |
86.9%
|
102.6%
|
37.8% |
Change turnover |
11,201
|
71,619
|
162,404 |
Change turnover % |
5%
|
45% | |
Chg. No. of employees |
6
|
5
|
4 |
Chg. No. of employees % |
55%
|
83%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.